KnE Life Sciences
ISSN: 2413-0877
The latest conference proceedings on life sciences, medicine and pharmacology.
Tuberculosis Epidemiological Surveillance in the Kolaka Regency Southeast Sulawesi
Published date: Sep 13 2022
Journal Title: KnE Life Sciences
Issue title: The 3rd International Conference on Advance & Scientific Innovation (ICASI) – Life Sciences Chapter
Pages: 209–213
Authors:
Abstract:
Tuberculosis is an infectious disease caused by the germ Mycobacterium tuberculosis. The group of Mycobacterium bacteria in addition to the Mycobacterium tuberculosis that can cause disorders of the airways is known as MOTT (Mycobacterium Other Than Tuberculosis), which can sometimes interfere with the enforcement of TB diagnosis and treatment. Tuberculosis (TB) is a high burden for Indonesia, which is not only because of the TB itself, but also its resistant to several first-line TB drug variance, namely multidrug resistant tuberculosis (MDR- TB). The development of tuberculosis in the Kolaka Regency has fluctuated every year. The highest number of cases in 2018 amounted to 426 patients. Enforcement of a diagnosis of tuberculosis requires several examinations, the administration of the drug for 6-12 months depending on the clinical criteria.
Keywords: Tuberculosis, Development
References:
[1] WHO, 2017. Global Tuberculosis Report 2017, Jenewa.
[2] Pratiwi, R. N., Winda, S., Suparno, A. S., & Tosepu, R. (2021, April). A Systematic Literatur The Impact Of The Climate To The Case Of Tuberculosis (TB): A Review. In IOP Conference Series: Earth and Environmental Science (Vol. 755, No. 1, p. 012089). IOP Publishing.
[3] Tosepu, R., & Jumakil, J. Hubungan Variabilitas Iklim Dengan Kejadian Tb Paru BTA Positif di Kota Kendari Tahun 2010-2018. Jurnal Kesehatan Lingkungan Universitas Halu Oleo, 1(2).
[4] Mongan, R., & Fajar, F. (2017). Relationship Between Family Support and Medical Compliance in Patients With Pulmonary Tuberculosis in the Working Area of the Community Health Center of Abeli, Kendari. Public Health of Indonesia, 3(1), 17-22.
[5] Asyary, A. (2018). RESPONSE: FACTORS RELATED TO THE SUCCESS OF THE TREATMENT PROGRAM OF MULTIDRUG-RESISTANT TUBERCULOSIS IN POLYCLINIC OF MDR-TB OF THE GENERAL HOSPITAL OF UNDATA PALU, INDONESIA. Public Health of Indonesia, 4(1), 37-38.
[6] Riset Kesehatan Dasar (Riskesdas) (2018). Badan Penelitian dan Pengembangan Kesehatan Kementerian RI tahun 2018. http://www.depkes.go.id/resources/download/infoterkini/materi_rakorpop_2018/Hasil%20Riskesdas%202018.pdf
[7] Acces on September 2021
[8] Dinas Kesehatan Provinsi Sulawesi Tenggara. 2020. Laporan Tahunan Dinas Kesehatan Provinsi Sulawesi Tenggara Tahun 2020. Kendari :Dinkes Sultra
[9] Cahyadi, A, Venty. TB Paru pada Pasien Diabetes Mellitus. J Indon Med Assoc. 2011;61:173-8
[10] Kementerian Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia no. 67 tahun 2016 tentang Penanggulangan tuberkulosis. Jakarta: Kementrian Kesehatan RI, 2016
[11] Milburn H, Ashman N, Davies P, Doffman S, Drobniewski F, Khoo S, et al. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax. 2010;65:5